Adeka Corporation
[Adeka] Financial Results for 2026 | Sales of ¥416.5 billion, Net Income of ¥27.8 billion
For the fiscal year ending March 2026, consolidated sales reached ¥416.5 billion (up 2.3% YoY), net income was ¥27.8 billion (up 11.4%), setting a record high. Segment-wise, Chemical Products, Food, and Life Sciences achieved revenue and profit growth. The outlook for the next period forecasts sales of ¥453.0 billion and net income of ¥28.8 billion.
Key Figures
- Sales Revenue: ¥416.5 billion (up 2.3% YoY)
- Net Income Attributable to Owners of Parent: ¥27.8 billion (up 11.4% YoY)
- Consolidated Total Assets: ¥559,987 million (up 3.1% YoY)
AI要約
Performance Overview
For the fiscal year ending March 2026, consolidated sales reached ¥416.5 billion (up 2.3% YoY), with net income of ¥27.8 billion (up 11.4%), marking a record high. Segments including Chemical Products, Food, and Life Sciences saw revenue and profit increases, with Life Sciences performing particularly well due to expanded sales overseas. The forecast for the next period anticipates sales of ¥453.0 billion and net income of ¥28.8 billion, indicating continued growth.
Shareholder Impact and Future Outlook
The company maintains a stable dividend, targeting a payout ratio of over 40%, with an expected dividend of ¥60 per share for the fiscal year ending March 2026. The next period also plans to increase dividends. Despite an uncertain business environment, investments will continue in growth fields such as semiconductors and pharmaceuticals to achieve long-term growth.
Adeka Co., Ltd.
Company overview · Stock price · Financial data · All IR
